Free US stock screening tools combined with expert analysis to help you identify undervalued companies with strong growth potential. We use sophisticated algorithms and human expertise to surface opportunities that might otherwise go unnoticed.
NovaBay Pharmaceuticals Inc. (NBY) is a specialty pharmaceutical company trading at a current price of $1.95 as of 2026-04-13, marking a 22.64% gain in recent trading activity. This analysis covers key technical levels to monitor for NBY, prevailing market context for the small-cap biotech sector, and potential near-term price scenarios based on current market data. No recent earnings data is available for the company as of the current date, so this analysis focuses primarily on technical and se
What accelerates growth of NovaBay Pharmaceuticals (NBY) Stock | Price at $1.95, Up 22.64% - Social Investment Platform
NBY - Stock Analysis
4553 Comments
613 Likes
1
Carlous
Loyal User
2 hours ago
I would clap, but my hands are tired from imagining it. ๐
๐ 260
Reply
2
Siwoo
Experienced Member
5 hours ago
Timing just wasnโt on my side this time.
๐ 84
Reply
3
Niccole
Regular Reader
1 day ago
Free US stock earnings analysis and guidance reviews to understand company fundamentals and future prospects for better investment decisions. Our earnings season coverage includes detailed analysis of financial results and what they mean for your investment thesis. We provide earnings previews, whisper numbers, and actual versus estimate analysis for comprehensive coverage. Understand earnings better with our comprehensive analysis and expert insights designed for informed decision making.
๐ 119
Reply
4
Rosanell
Returning User
1 day ago
Too lateโฆ oh well.
๐ 269
Reply
5
Talsha
Daily Reader
2 days ago
This is the kind of thing you only see too late.
๐ 257
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.